| Metric | Q1 2025 | Q4 2024 | Q1 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $13.9B | — | — | — | — |
| Op. Income | $1.3B | — | — | — | — |
| Gross Margin | 42.5% | — | — | — | — |
| Net Margin | 6.0% | — | — | — | — |
| EPS (Diluted) | $0.48 | — | — | — | — |
| Free Cash Flow | $3.5B | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $13.9B |
| Cost of Revenue | $8.0B |
| GROSS PROFIT | $5.9B |
| R&D Expenses | $0 |
| Selling & Marketing | $114M |
| General & Administrative | $2.0B |
| SG&A Expenses | $2.1B |
| Other Expenses | $4.7B |
| Operating Expenses | $6.8B |
| Cost & Expenses | $12.7B |
| OPERATING INCOME | $1.3B |
| Interest Income | $10.9B |
| Interest Expense | $7.2B |
| Other Income/Expenses | -$102M |
| INCOME BEFORE TAX | $1.2B |
| Income Tax Expense | $531M |
| Net Income from Continuing Ops | $726M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $838M |
| Net Income Deductions | $143M |
| BOTTOM LINE NET INCOME | $606M |
| D&A | $295M |
| EBIT | $981M |
| EBITDA | $1.3B |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $13.9B |
| Cost of Revenue | $8.0B |
| GROSS PROFIT | $5.9B |
| R&D Expenses | $0 |
| Selling & Marketing | $114M |
| General & Administrative | $2.0B |
| SG&A Expenses | $2.1B |
| Other Expenses | $4.7B |
| Operating Expenses | $6.8B |
| Cost & Expenses | $12.7B |
| OPERATING INCOME | $1.3B |
| Interest Income | $10.9B |
| Interest Expense | $7.2B |
| Other Income/Expenses | -$102M |
| INCOME BEFORE TAX | $1.2B |
| Income Tax Expense | $531M |
| Net Income from Continuing Ops | $726M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $838M |
| Net Income Deductions | $143M |
| BOTTOM LINE NET INCOME | $606M |
| D&A | $295M |
| EBIT | $981M |
| EBITDA | $1.3B |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $838M |
| Depreciation & Amortization | $295M |
| Stock-Based Compensation | $6M |
| Deferred Income Tax | $531M |
| Other Non-Cash Items | $550M |
| Change in Working Capital | $1.2B |
| OPERATING CASH FLOW | $3.5B |
| Capital Expenditure | -$6M |
| Acquisitions (Net) | -$2.1B |
| Purchases of Investments | -$12.5B |
| Sales/Maturities of Investments | $14.7B |
| Other Investing Activities | -$3.1B |
| NET CASH FROM INVESTING | -$3.0B |
| Net Debt Issuance | -$56M |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | -$965M |
| Other Financing Activities | -$309M |
| NET CASH FROM FINANCING | -$297M |
| FREE CASH FLOW | $3.5B |
| Net Change in Cash | $359M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $51.3B |
| Short-Term Investments | $89.5B |
| Net Receivables | $0 |
| Inventory | $0 |
| Other Current Assets | $0 |
| TOTAL CURRENT ASSETS | $140.8B |
| PP&E (Net) | $3.6B |
| Goodwill | $0 |
| Intangible Assets | $11.9B |
| Long-Term Investments | $627.7B |
| Tax Assets | $2.1B |
| Other Non-Current Assets | $265.7B |
| TOTAL NON-CURRENT ASSETS | $910.9B |
| TOTAL ASSETS | $1.1T |
| Account Payables | $0 |
| Short-Term Debt | $83.5B |
| Deferred Revenue | $0 |
| Other Current Liabilities | -$83.5B |
| TOTAL CURRENT LIABILITIES | $0 |
| Long-Term Debt | $142.4B |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $89.1B |
| TOTAL NON-CURRENT LIABILITIES | $231.5B |
| TOTAL LIABILITIES | $988.5B |
| Common Stock | $16.2B |
| Additional Paid-In Capital | $0 |
| Retained Earnings | $42.0B |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | -$3.7B |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $62.0B |
| Minority Interest | $1.2B |
| TOTAL EQUITY | $63.2B |
| TOTAL LIABILITIES & EQUITY | $1.1T |
| Total Debt | $225.9B |
| Net Debt | $174.6B |
